Showing 1 - 16 results of 16 for search 'Colin Kovacs', query time: 0.05s Refine Results
  1. 1
    Impact of collection method on assessment of semen HIV RNA viral load.

    Impact of collection method on assessment of semen HIV RNA viral load. by Brendan J W Osborne, Prameet M Sheth, Colin Kovacs, Tony Mazzulli, Rupert Kaul

    Published 2011-01-01
    Get full text
    Article
  2. 2
    21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo

    21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo by Adam Ward, Enock Charleus, Sara Karandish, Erika Benko, Colin Kovacs, Ali Ramezani, R. Brad Jones

    Published 2017-07-01
    Get full text
    Article
  3. 3
    HIV delays IFN-α production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation.

    HIV delays IFN-α production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation. by Calvin C Lo, Jordan A Schwartz, Dylan J Johnson, Monica Yu, Nasra Aidarus, Shariq Mujib, Erika Benko, Martin Hyrcza, Colin Kovacs, Mario A Ostrowski

    Published 2012-01-01
    Get full text
    Article
  4. 4
    Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.

    Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. by Manuela Fogli, Domenico Mavilio, Enrico Brunetta, Stefania Varchetta, Khaled Ata, Gregg Roby, Colin Kovacs, Dean Follmann, Daniela Pende, Jeffrey Ward, Edward Barker, Emanuela Marcenaro, Alessandro Moretta, Anthony S Fauci

    Published 2008-07-01
    Get full text
    Article
  5. 5
    HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection.

    HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection. by Bahareh Vali, Feng Yun Yue, R Brad Jones, Prameet M Sheth, Rupert Kaul, Michael R Betts, David Wong, Colin Kovacs, Mona Loutfy, Andrew Common, Roberta Halpenny, Mario A Ostrowski

    Published 2008-01-01
    Get full text
    Article
  6. 6
    Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes.

    Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. by Richard Brad Jones, Rachel O'Connor, Stefanie Mueller, Maria Foley, Gregory L Szeto, Dan Karel, Mathias Lichterfeld, Colin Kovacs, Mario A Ostrowski, Alicja Trocha, Darrell J Irvine, Bruce D Walker

    Published 2014-08-01
    Get full text
    Article
  7. 7
    Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.

    Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. by Ali Sakhdari, Shariq Mujib, Bahareh Vali, Feng Yun Yue, Sonya MacParland, Kiera Clayton, Richard Bradley Jones, Jun Liu, Erika Yue Lee, Erika Benko, Colin Kovacs, Jennifer Gommerman, Rupert Kaul, Mario A Ostrowski

    Published 2012-01-01
    Get full text
    Article
  8. 8
    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection. by Sonya A MacParland, Saleh M Fadel, Vesna Mihajlovic, Ali Fawaz, Connie Kim, A K M Nur-Ur Rahman, Jun Liu, Rupert Kaul, Colin Kovacs, Jason Grebely, Gregory J Dore, David K Wong, Mario A Ostrowski

    Published 2016-01-01
    Get full text
    Article
  9. 9
    Ex vivo Stimulatory Capacity of TLR3 and TLR4 is reduced in HIV-Infected Rapid Progressors and Enhanced Long-Term Non-Progressors

    Ex vivo Stimulatory Capacity of TLR3 and TLR4 is reduced in HIV-Infected Rapid Progressors and Enhanced Long-Term Non-Progressors by Steven E. Bosinger,1,2 Prameet M. Sheth,3 Ali Danesh,2,4 Leonard Noay,5 Roberta Halpenny,5 Shari Gordon,6,7,8 Silvija Staprans,7,8 Guido Silvestri,6 Colin Kovacs,5 Rupert Kaul,3 and David J. Kelvin.2,4

    Published 2007-08-01
    Get full text
    Article
  10. 10
    The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

    The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy by Natalie F. McMyn, Joseph Varriale, Emily J. Fray, Carolin Zitzmann, Hannah MacLeod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro A. Garcia, Brianna M. Lopez, Vivek Hariharan, Kyle Rhodehouse, Kenneth Lynn, Pablo Tebas, Karam Mounzer, Luis J. Montaner, Erika Benko, Colin Kovacs, Rebecca Hoh, Francesco R. Simonetti, Gregory M. Laird, Steven G. Deeks, Ruy M. Ribeiro, Alan S. Perelson, Robert F. Siliciano, Janet M. Siliciano

    Published 2023-09-01
    Get full text
    Article
  11. 11
    HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

    HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA) by Natalie N. Kinloch, Yanqin Ren, Winiffer D. Conce Alberto, Winnie Dong, Pragya Khadka, Szu Han Huang, Talia M. Mota, Andrew Wilson, Aniqa Shahid, Don Kirkby, Marianne Harris, Colin Kovacs, Erika Benko, Mario A. Ostrowski, Perla M. Del Rio Estrada, Avery Wimpelberg, Christopher Cannon, W. David Hardy, Lynsay MacLaren, Harris Goldstein, Chanson J. Brumme, Guinevere Q. Lee, Rebecca M. Lynch, Zabrina L. Brumme, R. Brad Jones

    Published 2021-01-01
    Get full text
    Article
  12. 12
    A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.

    A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. by R Brad Jones, Stefanie Mueller, Rachel O'Connor, Katherine Rimpel, Derek D Sloan, Dan Karel, Hing C Wong, Emily K Jeng, Allison S Thomas, James B Whitney, So-Yon Lim, Colin Kovacs, Erika Benko, Sara Karandish, Szu-Han Huang, Maria J Buzon, Mathias Lichterfeld, Alivelu Irrinki, Jeffrey P Murry, Angela Tsai, Helen Yu, Romas Geleziunas, Alicja Trocha, Mario A Ostrowski, Darrell J Irvine, Bruce D Walker

    Published 2016-04-01
    Get full text
    Article
  13. 13
    Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

    Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection by Minh Ha Ngo, Joshua Pankrac, Ryan C. Y. Ho, Emmanuel Ndashimye, Rahul Pawa, Renata Ceccacci, Tsigereda Biru, Abayomi S. Olabode, Katja Klein, Yue Li, Colin Kovacs, Robert Assad, Jeffrey M. Jacobson, David H. Canaday, Stephen Tomusange, Samiri Jamiru, Aggrey Anok, Taddeo Kityamuweesi, Paul Buule, Ronald M. Galiwango, Steven J. Reynolds, Thomas C. Quinn, Andrew D. Redd, Jessica L. Prodger, Jamie F. S. Mann, Eric J. Arts

    Published 2024-12-01
    Get full text
    Article
  14. 14
    Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

    Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA) by Natalie N. Kinloch, Yanqin Ren, Winiffer D. Conce Alberto, Winnie Dong, Pragya Khadka, Szu Han Huang, Talia M. Mota, Andrew Wilson, Aniqa Shahid, Don Kirkby, Marianne Harris, Colin Kovacs, Erika Benko, Mario A. Ostrowski, Perla M. Del Rio Estrada, Avery Wimpelberg, Christopher Cannon, W. David Hardy, Lynsay MacLaren, Harris Goldstein, Chanson J. Brumme, Guinevere Q. Lee, Rebecca M. Lynch, Zabrina L. Brumme, R. Brad Jones

    Published 2021-05-01
    Get full text
    Article
  15. 15
    The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells

    The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells by Dennis C. Copertino Jr., Carissa S. Holmberg, Jared Weiler, Adam R. Ward, J. Natalie Howard, Callie Levinger, Alina P.S. Pang, Michael J. Corley, Friederike Dündar, Paul Zumbo, Doron Betel, Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, Noemi Linden, Bernard J. Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, Colin Kovacs, Erika Benko, Alberto Bosque, R. Brad Jones, for the AIDS Clinical Trials Group (ACTG) A5321 Team

    Published 2023-09-01
    Get full text
    Article
  16. 16
    Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV

    Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV by Vitaliy A. Matveev, Erik Z. Mihelic, Erika Benko, Patrick Budylowski, Sebastian Grocott, Terry Lee, Chapin S. Korosec, Karen Colwill, Henry Stephenson, Ryan Law, Lesley A. Ward, Salma Sheikh-Mohamed, Geneviève Mailhot, Melanie Delgado-Brand, Adrian Pasculescu, Jenny H. Wang, Freda Qi, Tulunay Tursun, Lela Kardava, Serena Chau, Philip Samaan, Annam Imran, Dennis C. Copertino, Jr., Gary Chao, Yoojin Choi, Robert J. Reinhard, Rupert Kaul, Jane M. Heffernan, R. Brad Jones, Tae-Wook Chun, Susan Moir, Joel Singer, Jennifer Gommerman, Anne-Claude Gingras, Colin Kovacs, Mario Ostrowski

    Published 2023-10-01
    Get full text
    Article

Search Tools: